RE:RE:RE:RE:POCWell it has been brought up here soooo many times that step one is for IR to go after the retail investor, getting the volume up & SP above $5.00 so the big players are allowed to invest, wasn’t it spartrap that was trying hard to help on retail engagement and attempted many times to convince Thera of this? Guess he finally gave up and moved on.
jfm1330 wrote: My view on the stock price right now, given what I wrote the other day and many times before that is that only few shareholders are ready to sell at the actual price, but the company still does not have the big news in oncology to move things up significantly. That being said, in my opinion it's great entry point for a new investor that did his due diligence on publicly available facts. The bet on oncology, given the other assets the company has is very cheap. Maybe some will wake up to that in the coming weeks.
TH1902 wrote: With all due respect SPCEO, the market doesn't believe anything positive has happened yet. The senseless downgrades didn't help...lol...
I would like to believe we are under the radar, but if our news really was that good, we would have seen a reaction in the SP by now imo...more data points required to move the needle...
SPCEO1 wrote: Everyone will have their opinion on this but my read is we re already at a point where it is reasonably likely the key attributes for the success of TH-1902 are in place and th ekey causes of failure are absent.
palinc2000 wrote: A Google search of POC will lead to many many definitions none of which to suggest that we are at that point ATM ....
What is worst than fuzzy math is fuzzy science data ...
When and if POC is attained we will know just by seeing the market reaction $$$
“Proof of concept may be defined as the earliest point in the drug development process at which the weight of evidence suggests that it is "reasonably likely" that the key attributes for success are present and the key causes of failure are absent.” POC is a key translational pivot point ...